Geon Investment

Geon Investment Inc. is a venture capital firm established in 2009 and located in Seongnam, South Korea. The firm specializes in providing expansion stage and growth capital to companies primarily in the digital and mobile content, biotechnology, and mobile/online game sectors, as well as movie and music content industries. Geon Investment typically invests between KRW 500 million and KRW 2 billion in equity per transaction, targeting businesses that are poised for growth.

SeungHan Kang

Director

Young Moo Lee

Managing Director, Investment Division

18 past transactions

Albam

Series B in 2019
Albam : A mobile based HR Solution that is available for both Managers(Admins) and Staffs in App both IOS & Android. The average HR manager spends 45 minutes a day to calculate time attendance & payroll. With Albam, time is reduced by 70% to only 15 minutes. Albam help enterprises in simplifying and automating their time attendance system to payroll solution. Our easy to use and simple Cloud based Human Resource solution helps companies in reducing the high costs that are often associated in the investment of Time Attendance system which includes the purchase of expensive fingerprint machines and training of IT Personnels. With Albam, employees can clock in and clock out directly right away from their smartphone, clock in and clock out has never been this easier with Albam.

Newploy

Series B in 2019
Newploy is a South Korean company founded in 2014 that specializes in workforce management software. The platform is designed to streamline various aspects of employee management, including tracking work hours, attendance, and leave, as well as calculating salaries and managing payroll. By automating these processes, Newploy enables businesses to effectively centralize and manage their staffing needs, enhancing efficiency in human resource operations.

swIDch

Series A in 2018
swIDch is an information technology company based in London, established in 2015, that specializes in secure authentication solutions for digital identities. The company has developed a patented algorithm that allows clients to generate dynamic authentication codes, enabling secure access even in network-less environments. Their technology includes the generation of dynamic primary account numbers, facilitating secure offline transactions without displaying card numbers. This system supports standard EMV, contactless, and magnetic stripe payments, giving customers greater control over their transactions by allowing them to specify valid dates and create both dynamic and static virtual primary account numbers.

Neuraly

Series A in 2018
Neuraly, Inc. is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including Parkinson’s and Alzheimer’s diseases. Founded in 2016 and based in Germantown, Maryland, Neuraly emerged from pioneering research led by prominent neuroscientists at Johns Hopkins School of Medicine. The company is advancing several drug candidates, notably NLY01, a neuroprotective agent designed to inhibit pathological microglial activation, as well as NLY02 and NLY03, which are kinase inhibitors that penetrate the blood-brain barrier. Recent research published in Nature Medicine highlights the significance of glial cells in the progression of neurodegenerative disorders, underpinning Neuraly's therapeutic approach aimed at mitigating neuronal cell death. Neuraly operates as a subsidiary of D&D Pharmatech Co., Ltd.

D&D Pharmatech

Series A in 2018
D&D Pharmatech Co., Ltd. is a clinical-stage biotech company based in Seongnam, South Korea, established in 2014. The company focuses on developing innovative medicines across various therapeutic areas, including neurodegenerative, fibrotic, and metabolic diseases. It operates through disease-specific subsidiary companies that are guided by leading medical research faculty, facilitating the translation of advanced research into viable therapeutic products. D&D Pharmatech's expertise encompasses drug research and development, manufacturing quality control, and clinical development. Additionally, the company is involved in the development of positron emission tomography (PET) imaging biomarkers and single-cell sequencing technologies related to degenerative brain diseases. By leveraging advanced drug delivery technologies, such as PEGylation, D&D Pharmatech aims to enhance the effectiveness and outcomes of its therapeutic offerings.

OliPass

Venture Round in 2017
OliPass Corporation is a biotechnology company based in Yongin, South Korea, founded in 2006. The company specializes in developing therapeutic products using its proprietary PNA-based technologies. OliPass focuses on its innovative platform, which introduces cationic lipid moieties onto nucleobases. The company's product pipeline includes treatments for various conditions such as hypercholesterolemia, chemotherapy and radiotherapy sensitization, and Type II diabetes, among others.

Sugarhill

Series A in 2017
Sugarhill is a Korean company that develops a commercial real estate platform called Nemo.

Sugarhill

Venture Round in 2016
Sugarhill is a Korean company that develops a commercial real estate platform called Nemo.

Gamfs

Series B in 2015
Online/Mobile game developer

Mobirix

Series C in 2015
Mobirix is a mobile game provider. Mobirix provides contents that users can enjoy without age and cultural differences. Mobirix tries to make firm and cooperative relationships with partners to achieve mutual goals. Mobirix will try harder to provide the best gaming experience to millions of gamers all around the world. Player always comes first.

PICNEKO CREATIVE

Series A in 2015
Mobile Game

JP Company

Series B in 2015
Cosmetic venture

TCE Corporation

Venture Round in 2015
TCE Corporation, established in 1956 and headquartered in Busan, South Korea, specializes in the production of a wide range of fabrics for the textile industry. The company manufactures cotton, blended materials, corduroy, velveteen, denim, and various stretch fabrics, in addition to offering woven fabrics. TCE operates a sales office in Seoul and has international offices in Shanghai, China, and New York, USA, allowing it to serve a global market effectively.

G plus games

Series B in 2014
G Plus Games Co., Ltd. was founded in 2011 to create a new era of next gen online entertainment in the global market. By employs over 20 veteran developers who experienced to develop triple A online gaming products for many years, their goal is to create Final Bullet, next generation online shooter which can be published in over the world with groundbreaking brand-new technologies, features, functions and contents. As they are an independent studio, fully ready to work with any global publishers, on any platforms, and prepare any of culturalization and localization for game design, arts, digital materials, contents and development schedules in support their corporate vision.

Justnine

Series B in 2013
Justnine Co. Ltd. is a mobile app developer based in Seoul, South Korea, established in 2005. The company specializes in the development of online and new platform games, focusing on creating engaging gaming experiences for users. One of its notable products is "HELLKID: hook & jump," which showcases the company's expertise in mobile gaming. Justnine aims to innovate within the gaming industry by leveraging its experience in app development to deliver high-quality entertainment to a diverse audience.

Vooz Soft

Series A in 2012
Mobile Contents

PMD Academy

Series A in 2010
Education
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.